Where Does PTC Therapeutics, Inc. (PTCT) Stock Fall in the Biotechnology Field After It Is Lower By -2.79% This Week?

PTC Therapeutics, Inc. (PTCT) is near the bottom in its industry group according to InvestorsObserver. PTCT gets an overall rating of 22. That means it scores higher than 22 percent of stocks. PTC Therapeutics, Inc. gets a 12 rank in the Biotechnology industry. Biotechnology is number 93 out of 148 industries.

PTCT has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on PTCT!

See Full PTCT Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 22 means the stock is more attractive than 22 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With PTC Therapeutics, Inc. Stock Today?

PTC Therapeutics, Inc. (PTCT) stock is trading at $38.96 as of 10:51 AM on Thursday, Jan 6, a rise of $0.48, or 1.23% from the previous closing price of $38.48. The stock has traded between $37.24 and $39.23 so far today. Volume today is below average. So far 249,756 shares have traded compared to average volume of 729,085 shares. Click Here to get the full Stock Report for PTC Therapeutics, Inc. stock.